A detailed history of Sbi Securities Co., Ltd. transactions in Medicinova Inc stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 45,537 shares of MNOV stock, worth $69,671. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45,537
Previous 43,479 4.73%
Holding current value
$69,671
Previous $57 Million 1.54%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$1.22 - $1.45 $2,510 - $2,984
2,058 Added 4.73%
45,537 $57.8 Million
Q2 2025

Aug 07, 2025

SELL
$1.2 - $1.56 $15,120 - $19,656
-12,600 Reduced 22.47%
43,479 $57 Million
Q1 2025

May 01, 2025

BUY
$1.46 - $2.16 $3,369 - $4,985
2,308 Added 4.29%
56,079 $81.9 Million
Q4 2024

Feb 05, 2025

BUY
$1.53 - $2.38 $82,269 - $127,974
53,771 New
53,771 $113 Million

Others Institutions Holding MNOV

About MEDICINOVA INC


  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $75M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.